Italian cultural adaptation of the Memorial Anxiety for Prostate Cancer scale for the population of men on active surveillance

Abstract

Purpose:

The Memorial Anxiety Scale for Prostate Cancer (MAX-PC) is a self-report questionnaire that was developed in English to assess prostate cancer (PCa)-related anxiety. The aim of this study was to perform a cultural adaptation for the tool to be used in a population of Italian men on active surveillance (AS).

Methods:

A total of 222 patients with localized PCa who were recruited for the Prostate Cancer Research International: Active Surveillance (PRIAS) protocol completed the MAX-PC. Psychometric analysis was performed to assess reliability indexes. A Spearman rank correlation was used to test the association between MAX-PC scales and other questionnaires and was used for longitudinal analysis.

Results:

Cronbach coefficients and item to total correlation demonstrated good internal consistency. Some items related to the repetition of the PSA test showed a large floor effect and thus were poorly effective in measuring anxiety for PSA testing in patients on AS. Confirmatory factor analysis partly failed to reproduce the structure of the original version. A modified version of MAX-PC, excluding the items with a large floor effect, was thus considered for AS patients. Factor analysis on this version demonstrated considerable consistency with the presence of 3 subscales: anxiety related to PCa, anxiety related to PSA testing, and anxiety related to the fear of tumor progression. Longitudinal analysis showed an acceptable validity over time. The MAX-PC was correlated with the anxious preoccupation subscale of the Mini-Mental Adjustment to Cancer scale.

Conclusions:

A slightly modified version of the MAX-PC was developed for use in Italian men on AS. This instrument appears to be a valid and reliable tool that measures anxiety in men with PCa who are enrolled in AS programs.

Keywords

Active surveillance Memorial anxiety scale for prostate cancer Prostate cancer-related anxiety

Get full access to this article

View all access options for this article.

References

Ferlay

Steliarova-Foucher

Lortet-Tieulent

et al . Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer. 2013;49(6):1374-1403.

Cooperberg

Broering

Kantoff

Carroll

. Contemporary trends in low risk prostate cancer: risk assessment and treatment. J Urol. 2007;178(3 Pt 2):S14-S19.

Bokhorst

Kranse

Venderbos

et al . ERSPC Rotterdam Study Group. Differences in Treatment and Outcome After Treatment with Curative Intent in the Screening and Control Arms of the ERSPC Rotterdam. Eur Urol. 2015;68(2):179-182.

Mohler

Armstrong

Bahnson

et al . Prostate cancer, Version 3.2012: featured updates to the NCCN guidelines. J Natl Compr Canc Netw. 2012;10(9):1081-1087.

Heidenreich

Bastian

Bellmunt

et al . European Association of Urology. EAU guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent-update 2013. Eur Urol. 2014;65(1):124-137.

Graham

Kirkbride

Cann

Hasler

Prettyjohns

. Prostate cancer: summary of updated NICE guidance. BMJ. 2014;348(jan08 1):f7524.

Bangma

Valdagni

Carroll

van Poppel

Klotz

Hugosson

. Active surveillance for low-risk prostate cancer: developments to date. Eur Urol. 2015;67(4):646-648.

Bul

Zhu

Valdagni

et al . Active surveillance for low-risk prostate cancer worldwide: the PRIAS study. Eur Urol. 2013;63(4):597-603.

Klotz

Vesprini

Sethukavalan

et al . Long-term follow-up of a large active surveillance cohort of patients with prostate cancer. J Clin Oncol. 2015;33(3):272-277.

10.

Alam

Carter

Landis

Epstein

Mamawala

. Conditional probability of reclassification in an active surveillance program for prostate cancer. J Urol. 2015;193(6):1950-1955.

11.

Glass

Cooperberg

Meng

Carroll

. Role of active surveillance in the management of localized prostate cancer. J Natl Cancer Inst Monogr. 2012;2012(45):202-206.

12.

Bul

Zhu

Rannikko

et al . Radical prostatectomy for low-risk prostate cancer following initial active surveillance: results from a prospective observational study. Eur Urol. 2012;62(2):195-200.

13.

Repetto

Rancati

Magnani

et al . What if…: decisional regret in patients who discontinued active surveillance. Tumori. 2016;102(6):562-568.

14.

Villa

Kendel

Venderbos

et al . Setting an agenda for assessment of health-related quality of life among men with prostate cancer on active surveillance: a consensus paper from a european school of oncology task force. Eur Urol. 2017;71(2):274-280.

15.

Burnet

Parker

Dearnaley

Brewin

Watson

. Does active surveillance for men with localized prostate cancer carry psychological morbidity? BJU Int. 2007;100(3):540-543.

16.

Bellardita

Rancati

Alvisi

et al . Predictors of health-related quality of life and adjustment to prostate cancer during active surveillance. Eur Urol. 2013;64(1):30-36.

17.

Roth

Rosenfeld

Kornblith

et al . The memorial anxiety scale for prostate cancer: validation of a new scale to measure anxiety in men with with prostate cancer. Cancer. 2003;97(11):2910-2918.

18.

van den Bergh

Korfage

Borsboom

Steyerberg

Essink-Bot

. Prostate cancer-specific anxiety in Dutch patients on active surveillance: validation of the memorial anxiety scale for prostate cancer. Qual Life Res. 2009;18(8):1061-1066.

19.

Roth

Nelson

Rosenfeld

et al . Assessing anxiety in men with prostate cancer: further data on the reliability and validity of the Memorial Anxiety Scale for Prostate Cancer (MAX-PC). Psychosomatics. 2006;47(4):340-347.

20.

Guillemin

Bombardier

Beaton

. Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines. J Clin Epidemiol. 1993;46(12):1417-1432.

21.

Grassi

Buda

Cavana

Annunziata

Torta

Varetto

. Styles of coping with cancer: the Italian version of the Mini-Mental Adjustment to Cancer (Mini-MAC) scale. Psychooncology. 2005;14(2):115-124.

22.

Cella

Nichol

Eton

Nelson

Mulani

. Estimating clinically meaningful changes for the Functional Assessment of Cancer TherapyProstate: results from a clinical trial of patients with metastatic hormone-refractory prostate cancer. Value Health. 2009;12(1):124-129.

23.

Ware

Jr Sherbourne

. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30(6):473-483.

24.

Terwee

Bot

SDM

de Boer

et al . Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol. 2007 1;60(1):34-42.

25.

Aaronson

Alonso

Burnam

Lohr

Patrick

Perrin

et al . Assessing health status and quality-of-life instruments: attributes and review criteria. Qual Life Res. 2002 05;11(3):193-205.

26.

Churchill

Jr . A paradigm for developing better measures of marketing constructs. J Market Res. 1979:64-73.

27.

R Development Core Team. (2008). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. ISBN 3-900051-07-0, URL http://www.R-project.org.